These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 34791573

  • 1. Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement.
    Magaki S, Satyadev R, Chen Z, Yung KS, Vinters HV, Kinney MC, Said JW.
    Brain Tumor Pathol; 2022 Jan; 39(1):25-34. PubMed ID: 34791573
    [Abstract] [Full Text] [Related]

  • 2. Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.
    King RL, Dao LN, McPhail ED, Jaffe ES, Said J, Swerdlow SH, Sattler CA, Ketterling RP, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Gibson SE, Ondrejka SL, Nicolae A, Macon WR, Dasari S, Parrilla Castellar E, Feldman AL.
    Am J Surg Pathol; 2016 Jan; 40(1):36-43. PubMed ID: 26379151
    [Abstract] [Full Text] [Related]

  • 3. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.
    Parrilla Castellar ER, Jaffe ES, Said JW, Swerdlow SH, Ketterling RP, Knudson RA, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Vasmatzis G, Gibson SE, Ondrejka S, Nicolae A, Grogg KL, Allmer C, Ristow KM, Wilson WH, Macon WR, Law ME, Cerhan JR, Habermann TM, Ansell SM, Dogan A, Maurer MJ, Feldman AL.
    Blood; 2014 Aug 28; 124(9):1473-80. PubMed ID: 24894770
    [Abstract] [Full Text] [Related]

  • 4. Primary effusion anaplastic large cell lymphoma with indolent clinical course and IRF4/DUSP22 rearrangement: a case report expanding the spectrum of effusion-based lymphoma.
    Yuan CT, Cheng AL, Hou HA.
    Virchows Arch; 2023 Mar 28; 482(3):641-645. PubMed ID: 35984488
    [Abstract] [Full Text] [Related]

  • 5. Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements.
    Luchtel RA, Dasari S, Oishi N, Pedersen MB, Hu G, Rech KL, Ketterling RP, Sidhu J, Wang X, Katoh R, Dogan A, Kip NS, Cunningham JM, Sun Z, Baheti S, Porcher JC, Said JW, Jiang L, Hamilton-Dutoit SJ, Møller MB, Nørgaard P, Bennani NN, Chng WJ, Huang G, Link BK, Facchetti F, Cerhan JR, d'Amore F, Ansell SM, Feldman AL.
    Blood; 2018 Sep 27; 132(13):1386-1398. PubMed ID: 30093402
    [Abstract] [Full Text] [Related]

  • 6. DUSP22-IRF4 rearrangement in AIDS-associated ALK-negative anaplastic large cell lymphoma.
    Wang M, Kibbi N, Ring N, Siddon A, Foss F, Totonchy M.
    BMJ Case Rep; 2019 Sep 30; 12(9):. PubMed ID: 31570354
    [Abstract] [Full Text] [Related]

  • 7. Peripheral T-cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK-negative.
    Ganapathi KA, Nicolae A, Egan C, Geng H, Xi L, Pack SD, McFadden JR, Raffeld M, Jaffe ES, Pittaluga S.
    Br J Haematol; 2024 May 30; 204(5):1862-1871. PubMed ID: 38613165
    [Abstract] [Full Text] [Related]

  • 8. [Detection of chromosomal translocations of DUSP22 and TP63 in ALK-negative anaplastic large cell lymphoma by fluorescence in situ hybridization and related clinical relevance].
    Wang C, Chen X, Chen XY, He YH.
    Zhonghua Bing Li Xue Za Zhi; 2019 Oct 08; 48(10):791-795. PubMed ID: 31594044
    [Abstract] [Full Text] [Related]

  • 9. Primary cutaneous anaplastic large-cell lymphoma with DUSP22-IRF4 rearrangement following insect bites.
    Zhang Y, Chen M, Yu Y, Liu X, Liu W, Jiang L, Zhang W.
    J Cutan Pathol; 2022 Feb 08; 49(2):187-190. PubMed ID: 34622970
    [Abstract] [Full Text] [Related]

  • 10. Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma.
    Ravindran A, Feldman AL, Ketterling RP, Dasari S, Rech KL, McPhail ED, Kurtin PJ, Shi M.
    Am J Surg Pathol; 2021 Apr 01; 45(4):550-557. PubMed ID: 33165091
    [Abstract] [Full Text] [Related]

  • 11. DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma.
    Qiu L, Tang G, Li S, Vega F, Lin P, Wang SA, Wang W, Iyer SP, Malpica L, Miranda RN, Konoplev S, Tang Z, Fang H, Medeiros LJ, Xu J.
    Haematologica; 2023 Jun 01; 108(6):1604-1615. PubMed ID: 36453104
    [Abstract] [Full Text] [Related]

  • 12. ALCL by any other name: the many facets of anaplastic large cell lymphoma.
    Irshaid L, Xu ML.
    Pathology; 2020 Jan 01; 52(1):100-110. PubMed ID: 31706671
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma.
    Feldman AL, Oishi N, Ketterling RP, Ansell SM, Shi M, Dasari S.
    Am J Surg Pathol; 2022 Nov 01; 46(11):1490-1499. PubMed ID: 35941721
    [Abstract] [Full Text] [Related]

  • 14. Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma.
    Xing X, Flotte TJ, Law ME, Blahnik AJ, Chng WJ, Huang G, Knudson RA, Ketterling RP, Porcher JC, Ansell SM, Sidhu J, Dogan A, Feldman AL.
    Appl Immunohistochem Mol Morphol; 2015 Sep 01; 23(8):580-9. PubMed ID: 25390351
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation.
    Bisig B, Cairoli A, Gaide O, Somja J, Bregnard C, Gaulard P, Xerri L, Lefort K, Missiaglia E, Gilliet M, Hohl D, Guenova E, de Leval L.
    Virchows Arch; 2022 Oct 01; 481(4):653-657. PubMed ID: 35366115
    [Abstract] [Full Text] [Related]

  • 18. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
    Samols MA, Su A, Ra S, Cappel MA, Louissant A, Knudson RA, Ketterling RP, Said J, Binder S, Harris NL, Feldman AL, Kim J, Kim YH, Gratzinger D.
    Am J Surg Pathol; 2014 Sep 01; 38(9):1203-11. PubMed ID: 24805854
    [Abstract] [Full Text] [Related]

  • 19. ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study.
    Sibon D, Bisig B, Bonnet C, Poullot E, Bachy E, Cavalieri D, Fataccioli V, Bregnard C, Drieux F, Bruneau J, Lemonnier F, Dupuy A, Bossard C, Parrens M, Bouabdallah K, Ketterer N, Berthod G, Cairoli A, Damaj G, Tournilhac O, Jais JP, Gaulard P, De Leval L.
    Haematologica; 2023 Jun 01; 108(6):1590-1603. PubMed ID: 36453105
    [Abstract] [Full Text] [Related]

  • 20. JAK/STAT3 Signaling Activation Related to Distinct Clinicopathologic Features in Systemic ALK - Anaplastic Large Cell Lymphomas : New Insights into Their Heterogeneity.
    Wang JC, Zhong LH, Lin WQ, Zhang WF, Xi YF, Liu YP, Zhu Q, Liu W, Zhu WF, Chen YP, Chen G.
    Am J Surg Pathol; 2023 Jan 01; 47(1):55-64. PubMed ID: 36315833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.